JP2023135411A - Valved graft forming substrate - Google Patents

Valved graft forming substrate Download PDF

Info

Publication number
JP2023135411A
JP2023135411A JP2022040595A JP2022040595A JP2023135411A JP 2023135411 A JP2023135411 A JP 2023135411A JP 2022040595 A JP2022040595 A JP 2022040595A JP 2022040595 A JP2022040595 A JP 2022040595A JP 2023135411 A JP2023135411 A JP 2023135411A
Authority
JP
Japan
Prior art keywords
base material
valve
leaflet
auxiliary
space
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022040595A
Other languages
Japanese (ja)
Inventor
武 寺澤
Takeshi Terasawa
能明 武輪
Yoshiaki Takewa
雄介 井上
Yusuke Inoue
康史 佐藤
Yasushi Sato
泰秀 中山
Yasuhide Nakayama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahikawa Medical University NUC
Biotube Co Ltd
Original Assignee
Asahikawa Medical University NUC
Biotube Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahikawa Medical University NUC, Biotube Co Ltd filed Critical Asahikawa Medical University NUC
Priority to JP2022040595A priority Critical patent/JP2023135411A/en
Publication of JP2023135411A publication Critical patent/JP2023135411A/en
Pending legal-status Critical Current

Links

Images

Abstract

To provide a valved graft forming substrate by which a vessel can be formed with a desired thickness.SOLUTION: A valve leaflet formation surface 9 on a body side is set on a columnar substrate body 6. A valve leaflet formation surface 10 on an auxiliary side is set on an auxiliary substrate 7. The auxiliary substrate 7 is freely detachably installed on the end of the substrate body 6. A space between the valve leaflet formation surface 9 on the body side and the valve leaflet formation surface 10 on the auxiliary side is defined as a valve leaflet formation space 12. On the outer peripheral side of the substrate body 6 and the auxiliary substrate 7, there is installed a cylindrical cover substrate 8. A space between the outer peripheral surface of the substrate body 6 as well as of the auxiliary substrate 7 and the inner peripheral surface of the cover substrate 8 is defined as a vessel formation space 13. By installing in an environment in which a biological tissue material exists, a connective tissue is formed on the substrate surface, with a valved graft formed.SELECTED DRAWING: Figure 1

Description

本発明は、生体組織材料の存在する環境に設置して基材表面に結合組織を形成し、導管から半径方向内向きに膨出する複数の弁尖を有する弁付きグラフトを形成するための弁付きグラフト形成基材に関するものである。 The present invention provides a valve for forming a valve graft having a plurality of leaflets bulging radially inward from a conduit by placing it in an environment where biological tissue material is present to form connective tissue on the surface of the base material. The present invention relates to a graft-forming substrate.

病気や事故で失われた細胞、組織、器官を、人工素材や細胞により再び蘇らせる再生医療の研究が数多くなされている。 Much research is being conducted into regenerative medicine, which uses artificial materials and cells to revive cells, tissues, and organs that have been lost due to disease or accidents.

通常、身体には自己防衛機能があり、体内の浅い位置にトゲ等の異物が侵入した場合には、これを体外へ押し出そうとする。また、体内の深い位置に異物が侵入した場合には、その周りに繊維芽細胞が徐々に集まって、主に繊維芽細胞とコラーゲンからなる結合組織体のカプセルを形成して異物を覆うことにより、体内において異物を隔離することが知られている。この後者の自己防衛反応を利用して生細胞から生体由来組織を形成する技術として、生体内に異物としての基材を埋入して結合組織体を形成する技術が複数報告されている(特許文献1~3参照)。 Normally, the body has a self-defense function, and when a foreign object such as a thorn invades a shallow part of the body, it tries to push it out of the body. In addition, when a foreign object enters a deep position in the body, fibroblasts gradually gather around it and form a capsule of connective tissue mainly composed of fibroblasts and collagen to cover the foreign object. , is known to isolate foreign substances within the body. As a technique for forming biological tissue from living cells by utilizing this latter self-defense reaction, several techniques have been reported in which a connective tissue body is formed by implanting a base material as a foreign substance in a living body (patented). (See References 1 to 3).

さらに、特許文献4は、生体内などに基材を配置して基材表面に結合組織を形成し、外管部から半径方向内向きに膨出する複数の弁葉を有する人工弁を形成するための人工弁形成基材を開示している。 Further, Patent Document 4 discloses that a base material is placed in a living body, connective tissue is formed on the surface of the base material, and an artificial valve having a plurality of leaflets that bulges radially inward from an outer tube part is formed. Discloses a prosthetic valvuloplasty base material for.

特開2007-312821号公報JP2007-312821A 特開2008-237896号公報Japanese Patent Application Publication No. 2008-237896 特開2010-094476号公報Japanese Patent Application Publication No. 2010-094476 WO2016/098877A1(請求項1)WO2016/098877A1 (Claim 1)

ところが、特許文献4に記載の基材は、弁葉形成空間で所望の形状及び厚さの弁葉(弁尖)を形成することができるものの、基材本体及びカバー部材の周囲に形成された結合組織をそのまま外管部(導管)とするものであり、外管部(導管)を所望の厚さに形成することはできない。 However, although the base material described in Patent Document 4 can form valve leaflets (valve leaflets) of a desired shape and thickness in the leaflet formation space, the base material is The connective tissue is directly used as the outer tube (conduit), and the outer tube (conduit) cannot be formed to a desired thickness.

本発明は、導管を所望の厚さに形成することのできる弁付きグラフト形成基材の提供を目的とする。 The present invention seeks to provide a valved grafting substrate in which a conduit can be formed to a desired thickness.

上記目的を達成するために、本発明に係る弁付きグラフト形成基材は、生体組織材料の存在する環境に設置して基材表面に結合組織を形成し、導管から半径方向内向きに膨出する複数の弁尖を有する弁付きグラフトを形成するためのものであり、柱状の基材本体と、この基材本体の端部に着脱自在に取り付けられる補助基材とを備えたものである。さらに、その基材本体及び補助基材に、弁尖厚さに対応する間隔をあけて対向する本体側弁尖形成面及び補助側弁尖形成面をそれぞれ設定し、この本体側弁尖形成面と補助側弁尖形成面との間を、外縁の侵入口から結合組織を侵入させて弁付きグラフトの弁尖を形成する弁尖形成空間とし、また、基材本体及び補助基材の外周側に筒状のカバー基材を設け、基材本体及び補助基材の外周面とカバー基材の内周面とを導管厚さに対応する間隔をあけて対向させ、基材本体及び補助基材の外周面とカバー基材の内周面との間を、結合組織を侵入させて弁付きグラフトの導管を形成する導管形成空間としたものである。 In order to achieve the above object, the valved graft-forming base material according to the present invention is placed in an environment where biological tissue material is present to form connective tissue on the base material surface, and bulges radially inward from the conduit. This is for forming a valved graft having a plurality of valve leaflets, and includes a columnar base material body and an auxiliary base material that is detachably attached to the end of this base material body. Furthermore, a main body side leaflet formation surface and an auxiliary side leaflet formation surface are set on the base material main body and the auxiliary base material, respectively, and are opposed to each other with an interval corresponding to the leaflet thickness, and this main body side leaflet formation surface The space between the base material body and the auxiliary side leaflet formation surface is used as a leaflet formation space in which connective tissue enters from the entry port on the outer edge to form the leaflet of the valved graft, and the outer peripheral side of the base material body and the auxiliary base material A cylindrical cover base material is provided in the base material main body and the auxiliary base material, and the outer peripheral surface of the base material main body and the auxiliary base material and the inner peripheral surface of the cover base material are opposed to each other with an interval corresponding to the conduit thickness. A conduit forming space is formed between the outer circumferential surface of the graft and the inner circumferential surface of the cover base material, into which connective tissue is allowed to enter to form a conduit of the valved graft.

上記構成によれば、基材本体及び補助基材の外周側に筒状のカバー基材を設けて導管形成空間を構成するので、この導管形成空間に結合組織を侵入させて、所望の厚さの導管を形成することができる。しかも、基材本体及び補助基材とカバー基材との間に導管を形成するので、単に基材本体及び補助基材の外周側に導管を形成するよりも、その強度等の品質を高めることができる。 According to the above configuration, the cylindrical cover base material is provided on the outer peripheral side of the base material main body and the auxiliary base material to constitute the conduit formation space, so connective tissue is allowed to enter the conduit formation space to achieve the desired thickness. can form a conduit. Moreover, since a conduit is formed between the base material main body and auxiliary base material and the cover base material, quality such as strength can be improved compared to simply forming a conduit on the outer circumferential side of the base material main body and auxiliary base material. I can do it.

また、基材本体及び補助基材に本体側弁尖形成面及び補助側弁尖形成面を設定するので、その両面間に構成される弁尖形成空間に、その外縁の侵入口から結合組織を侵入させて弁尖を形成しつつ、侵入口に、導管と弁尖の端部との接続部を形成することができる。 In addition, since the main body side leaflet formation surface and the auxiliary side leaflet formation surface are set on the base material main body and the auxiliary base material, the connective tissue is injected into the leaflet formation space formed between the two surfaces from the entrance at the outer edge. While the valve leaflet is being entered, a connection between the conduit and the end of the leaflet can be formed at the entry port.

これにより、弁尖の端部を高品質かつ所望の厚さの導管で支持した構造の弁付きグラフトを形成することができ、その弁尖が流体の圧力を受けて径方向に撓むことによって流路を開閉するようにすることができる。 This makes it possible to form a valved graft in which the ends of the valve leaflets are supported by conduits of high quality and desired thickness, and the valve leaflets flex radially under the pressure of the fluid. The channel can be opened and closed.

ここで、「結合組織」とは、通常は、コラーゲンを主成分とする組織であって、生体内に形成される組織のことをいうが、本明細書及び特許請求の範囲の記載においては、生体内に形成される結合組織に相当する組織が生体外の環境下で形成される場合のその組織をも含む概念である。 Here, "connective tissue" usually refers to a tissue whose main component is collagen and is formed in a living body, but in the description of this specification and claims, This concept also includes tissues that correspond to connective tissue formed in a living body but are formed in an environment outside the living body.

また、「生体組織材料」とは、所望の生体由来組織を形成するうえで必要な物質のことであり、例えば、線維芽細胞、平滑筋細胞、内皮細胞、幹細胞、ES細胞、iPS細胞等の動物細胞、各種たんぱく質類(コラーゲン、エラスチン)、ヒアルロン酸等の糖類、その他、細胞成長因子、サイトカイン等の生体内に存在する各種の生理活性物質が挙げられる。この「生体組織材料」には、ヒト、イヌ、ウシ、ブタ、ヤギ、ヒツジ等の哺乳類動物、鳥類、魚類、その他の動物に由来するもの、又はこれと同等の人工材料が含まれる。 In addition, "biological tissue materials" refer to substances necessary for forming desired biological tissue, such as fibroblasts, smooth muscle cells, endothelial cells, stem cells, ES cells, iPS cells, etc. Examples include animal cells, various proteins (collagen, elastin), sugars such as hyaluronic acid, and various physiologically active substances existing in living bodies such as cell growth factors and cytokines. This "biological tissue material" includes materials derived from mammals such as humans, dogs, cows, pigs, goats, and sheep, birds, fish, and other animals, or equivalent artificial materials.

また、「生体組織材料の存在する環境」とは、動物(ヒト、イヌ、ウシ、ブタ、ヤギ、ヒツジ等の哺乳類動物、鳥類、魚類、その他の動物)の生体内(例えば、四肢部、肩部、背部又は腹部などの皮下、もしくは腹腔内への埋入)、又は、動物の生体外において、生体組織材料を含有する人工環境のことをいう。 In addition, "environment in which biological tissue materials exist" refers to the inside of an animal (human, dog, cow, pig, goat, sheep, and other mammals, birds, fish, and other animals) (e.g., limbs, shoulders, etc.). It refers to an artificial environment containing living tissue materials, either subcutaneously (implanted in the abdomen, back, or abdomen), or in vitro in an animal.

さらに、補助基材に、弁尖形成空間のうちの弁尖の先端部に対応する部位と基材外部とを連通する弁先孔を形成するようにしてもよい。 Furthermore, a valve tip hole may be formed in the auxiliary base material, which communicates a portion of the valve leaflet formation space corresponding to the distal end of the valve leaflet with the outside of the base material.

この構成によると、弁先孔を介して弁尖形成空間と基材外部とを連通するので、導管形成空間及び侵入口を介して結合組織を基材外部から弁尖形成空間に侵入させるだけでなく、弁先孔を介して結合組織を基材外部から直に弁尖形成空間に侵入させることができ、その分、弁尖の形成に要する時間を短くすることができる。 According to this configuration, the valve leaflet formation space and the outside of the base material are communicated through the valve tip hole, so connective tissue can simply enter the leaflet formation space from the outside of the base material through the conduit formation space and the entry port. Instead, the connective tissue can directly enter the valve leaflet formation space from outside the base material through the valve tip hole, and the time required to form the valve leaflets can be shortened accordingly.

つまり、基材本体及び補助基材の外周側にカバー基材を設けるので、結合組織は、カバー基材の内側の導管形成空間に侵入した後、侵入口から弁尖形成空間に侵入する必要があり、その分、弁尖の形成に要する時間が長くなりやすい。これに対して、補助基材に弁先孔を形成して、弁尖形成空間と基材外部とを連通することにより、弁先孔からも結合組織を侵入させることができ、弁尖の形成が遅れるのを防止することができる。 In other words, since the cover base material is provided on the outer periphery of the base material body and the auxiliary base material, the connective tissue needs to enter the duct formation space inside the cover base material and then enter the valve leaflet formation space through the entry port. However, the time required to form the valve leaflets tends to be longer. On the other hand, by forming a valve tip hole in the auxiliary base material and communicating the valve leaflet formation space with the outside of the base material, the connective tissue can also enter through the valve tip hole, and the formation of the valve leaflet. can prevent delays.

さらに、弁尖形成空間を弁尖の閉鎖状態の形状に設定し、複数の弁尖の先端部に対応する部位と基材外部とを連通する共通の弁先孔を形成するようにしてもよい。 Furthermore, the valve leaflet formation space may be set in the shape of the valve leaflet in the closed state, and a common valve tip hole may be formed that communicates the portion corresponding to the tips of the plurality of valve leaflets with the outside of the base material. .

この構成によると、弁尖形成空間を弁尖の閉鎖状態の形状に設定するので、複数の弁尖形成空間の先端部を互いに近づけることができ、各弁尖形成空間の先端部に形成する弁先孔を一体化して共通化することができる。これにより、弁先孔の基材外部への開口を大きくすることができ、基材外部から弁先孔に結合組織を侵入させやすくして、高品質の弁尖をより確実に形成すると共に、その弁尖の形成に要する時間を短くすることができる。 According to this configuration, the leaflet formation space is set in the shape of the valve leaflet in the closed state, so the tips of the plurality of leaflet formation spaces can be brought closer to each other, and the valve formed at the tip of each leaflet formation space can be moved closer to each other. The tip holes can be integrated and shared. This makes it possible to enlarge the opening of the valve tip hole to the outside of the base material, making it easier for connective tissue to enter the valve tip hole from the outside of the base material, and forming high-quality valve leaflets more reliably. The time required to form the valve leaflets can be shortened.

しかも、弁尖形成空間を弁尖の閉鎖状態の形状に設定することにより、弁尖を閉鎖状態に形成することができ、弁尖を開放状態に形成した場合と比較して、体内に移植した弁付きグラフトについて、弁尖の閉鎖の遅れなどに起因して逆流を生じさせる可能性を抑えることができる。 Moreover, by setting the valve leaflet formation space to the shape of the valve leaflets in the closed state, the valve leaflets can be formed in the closed state, and compared to the case where the leaflets are formed in the open state, it is possible to form the valve leaflets in the closed state. For valved grafts, the possibility of regurgitation due to delayed closure of the valve leaflets can be reduced.

さらに、補助基材に、弁尖形成空間を導管形成空間と連通して弁尖形成空間への結合組織の侵入を促進する促進孔を形成すると共に、補助基材の端面から促進孔に至る範囲に、促進孔の内部に形成された結合組織を切断するための切断用スリットを形成するようにしてもよい。 Furthermore, a promoting hole is formed in the auxiliary base material to communicate the valve leaflet formation space with the conduit forming space and promote the invasion of connective tissue into the valve leaflet forming space, and an area extending from the end surface of the auxiliary base material to the promoting hole. Additionally, a cutting slit for cutting the connective tissue formed inside the promoting hole may be formed.

この構成によると、補助基材に促進孔を形成するので、補助基材の外側の導管形成空間から内側の弁尖形成空間への結合組織の侵入を促進することができる。この場合、促進孔の内部に形成された結合組織によって、補助基材を挟んで弁付きグラフトの導管と弁尖とが連結されることになるが、補助基材に切断用スリットを形成するので、促進孔の内部に形成された結合組織を容易に切断することができる。これにより、弁付きグラフトを効率よく形成しつつ、その弁付きグラフトを損傷させることなく、弁付きグラフト形成基材から取り外すことができる。 According to this configuration, since the promoting hole is formed in the auxiliary base material, it is possible to promote the invasion of connective tissue from the conduit formation space on the outside of the auxiliary base material to the valve leaflet formation space on the inside. In this case, the connective tissue formed inside the promoting hole will connect the conduit of the valved graft to the valve leaflet with the auxiliary base material in between, but since a cutting slit is formed in the auxiliary base material, , the connective tissue formed inside the promoting hole can be easily cut. This allows the valved graft to be efficiently formed and removed from the valved graft forming substrate without damaging the valved graft.

上記のとおり、本発明によると、基材本体及び補助基材の外周側に筒状のカバー基材を設けて導管形成空間を構成し、この導管形成空間に結合組織を侵入させて導管を形成するので、弁付きグラフトの導管を所望の厚さに形成すると共に、その強度等の品質を高めることができる。 As described above, according to the present invention, a cylindrical cover base material is provided on the outer peripheral side of the base material main body and the auxiliary base material to constitute a conduit forming space, and connective tissue is infiltrated into this conduit forming space to form a conduit. Therefore, the conduit of the valved graft can be formed to a desired thickness and its quality such as strength can be improved.

また、本体側弁尖形成面と補助側弁尖形成面との間の弁尖形成空間に、その外縁の侵入口を介して導管形成空間から結合組織を侵入させることにより、弁尖形成空間に弁付きグラフトの弁尖を形成しつつ、侵入口に、導管と弁尖の端部との接続部を形成することができる。 In addition, by invading the connective tissue from the conduit formation space into the leaflet formation space between the main body side leaflet formation surface and the auxiliary side leaflet formation surface through the entry port on the outer edge, the valve leaflet formation space is While forming the leaflet of the valved graft, a connection between the conduit and the end of the leaflet can be formed at the entry port.

本発明に係る弁付きグラフト形成基材の斜視図A perspective view of a valved graft-forming substrate according to the present invention カバー基材を取り外した基材本体及び補助基材の斜視図Perspective view of the base material body and auxiliary base material with the cover base material removed 図2を反対側から見た斜視図Perspective view of Figure 2 from the opposite side 基材本体の斜視図Perspective view of the base material body (a)は基材本体の平面図、(b)はA-A断面図(a) is a plan view of the base material body, (b) is a sectional view taken along A-A 弁付きグラフト形成基材を用いて弁付きグラフトを形成する手順を説明する図Diagram illustrating the procedure for forming a valved graft using a valved graft formation base material 弁付きグラフトの斜視図で、(a)は閉鎖状態を示し、(b)は開放状態を示すFIG. 2 is a perspective view of a valved graft, (a) showing the closed state and (b) showing the open state.

以下、本発明に係る弁付きグラフト形成基材を実施するための形態について、図面を用いて説明する。 EMBODIMENT OF THE INVENTION Hereinafter, the form for implementing the valved graft formation base material based on this invention is demonstrated using drawing.

図1~図5に示すように、弁付きグラフト形成基材1は、生体組織材料の存在する環境に設置して基材表面に結合組織2を形成し、導管3から半径方向内向きに膨出する複数の弁尖4を有する例えば心臓弁グラフトとして用いられる弁付きグラフト5を形成するためのものであり、柱状の基材本体6と、基材本体6の端部に着脱自在に取り付けられる補助基材7と、基材本体6及び補助基材7の外周側に設けられる筒状のカバー基材8と、を備えたものである。 As shown in FIGS. 1 to 5, a valved graft-forming substrate 1 is placed in an environment where biological tissue material is present to form connective tissue 2 on the substrate surface and expand radially inward from a conduit 3. It is for forming a valve graft 5 which is used as a heart valve graft, for example, and has a plurality of valve leaflets 4 that extend out, and is detachably attached to a columnar base material body 6 and an end of the base material body 6. It includes an auxiliary base material 7 and a cylindrical cover base material 8 provided on the outer peripheral side of the base material main body 6 and the auxiliary base material 7.

さらに、基材本体6及び補助基材7には、弁尖厚さに対応する間隔をあけて対向する本体側弁尖形成面9及び補助側弁尖形成面10がそれぞれ設定され、両弁尖形成面9、10の間が、外縁の侵入口11から結合組織2を侵入させて弁付きグラフト5の弁尖4を形成する弁尖形成空間12とされ、また、基材本体6及び補助基材7の外周面とカバー基材8の内周面とが導管厚さに対応する間隔をあけて対向し、その両面間が、結合組織2を侵入させて弁付きグラフト5の導管3を形成する導管形成空間13とされる。 Furthermore, a main body side leaflet formation surface 9 and an auxiliary side leaflet formation surface 10 are respectively set on the base material main body 6 and the auxiliary base material 7 with an interval corresponding to the leaflet thickness. The space between the formation surfaces 9 and 10 is a leaflet formation space 12 in which the connective tissue 2 enters through the entry port 11 at the outer edge to form the leaflet 4 of the valved graft 5. The outer circumferential surface of the material 7 and the inner circumferential surface of the cover base material 8 face each other with an interval corresponding to the thickness of the conduit, and the connective tissue 2 is allowed to enter between these surfaces to form the conduit 3 of the valved graft 5. A conduit forming space 13 is formed.

基材本体6は、例えばアクリル樹脂などの高分子材料よりなる円柱状とされ、その端部に、中央のY字形の仕切り壁14によって仕切られた3面の本体側弁尖形成面9が形成されている。各本体側弁尖形成面9は、仕切り壁14の壁面と、その下縁から基材中心軸方向に傾斜しつつ半径方向外側に向かって広がる曲面とからなり、閉鎖状態の弁尖4の上流面に対応する形状に設定される。 The base body 6 has a cylindrical shape made of a polymeric material such as acrylic resin, and has three body-side leaflet formation surfaces 9 partitioned by a central Y-shaped partition wall 14 at its ends. has been done. Each main body-side valve leaflet formation surface 9 is composed of the wall surface of the partition wall 14 and a curved surface that extends radially outward while being inclined from the lower edge in the direction of the center axis of the base material, and is upstream of the valve leaflet 4 in the closed state. The shape is set to correspond to the surface.

本体側弁尖形成面9は、例えば、弁径(D)、弁閉鎖角(θ)、弁中心長(L)、交連部高さ(H)及び交連部間距離(a)の5変数を用いて、いわゆる非一様有理Bスプライン(NURBS)による補間処理をして設定することができる。ここで、弁径(D)は、基材本体6の外径に対応し、弁閉鎖角(θ)は、例えば20degで本体側弁尖形成面9の外縁における基材横断面に対する傾斜角に対応し、弁中心長(L)は、例えば13.5mmで仕切り壁14の下縁から本体側弁尖形成面9の外縁に至る長さに対応し、交連部高さ(H)は、例えば14.2mmで本体側弁尖形成面9の外縁から仕切り壁14の先端までの基材中心軸方向の高さに対応し、交連部間距離(a)は、仕切り壁14の厚さに対応する。 The main body side valve leaflet formation surface 9 has five variables, for example, valve diameter (D), valve closure angle (θ), valve center length (L), commissure height (H), and distance between commissures (a). It can be set by using interpolation processing using a so-called non-uniform rational B-spline (NURBS). Here, the valve diameter (D) corresponds to the outer diameter of the base material main body 6, and the valve closing angle (θ) is, for example, 20 deg, which corresponds to the inclination angle with respect to the base material cross section at the outer edge of the main body side valve leaflet formation surface 9. Correspondingly, the valve center length (L) is, for example, 13.5 mm, which corresponds to the length from the lower edge of the partition wall 14 to the outer edge of the main body side valve leaflet formation surface 9, and the commissure height (H) is, for example, 14.2 mm corresponds to the height in the direction of the center axis of the base material from the outer edge of the valve leaflet formation surface 9 on the main body side to the tip of the partition wall 14, and the distance between commissures (a) corresponds to the thickness of the partition wall 14. do.

仕切り壁14の半径方向外端縁には、切欠き15が形成され、互いに隣接する弁尖形成空間12を十分な厚さの空間で連続させて、弁付きグラフト5に、十分な厚さで所定の強度を有する交連部16を形成するようになっている。 A notch 15 is formed in the outer edge of the partition wall 14 in the radial direction so that the adjacent leaflet formation spaces 12 are continuous with a space of sufficient thickness, and the valve graft 5 is formed with a sufficient thickness. A commissure portion 16 having a predetermined strength is formed.

補助基材7は、例えばアクリル樹脂などの高分子材料からなる円柱状とされ、基材中央側の端面から基材外端側の端板17に至る範囲に形成されたY字形のスリット18の内面と、スリット18で3分割された基材中央側の端面とが、補助側弁尖形成面10を構成する。スリット18に仕切り壁14を挿入して、その壁先部19を端板17に形成された嵌合溝20に嵌め込むことにより、基材本体6の端部に補助基材7が取り付けられると共に、補助側弁尖形成面10が本体側弁尖形成面9に対向して弁尖形成空間12を構成する。 The auxiliary base material 7 is made of a polymeric material such as acrylic resin and has a cylindrical shape, and has a Y-shaped slit 18 formed in a range from the end surface on the center side of the base material to the end plate 17 on the outer end side of the base material. The inner surface and the end surface on the center side of the base material divided into three by the slit 18 constitute the auxiliary leaflet formation surface 10. By inserting the partition wall 14 into the slit 18 and fitting the wall tip 19 into the fitting groove 20 formed in the end plate 17, the auxiliary base material 7 is attached to the end of the base material main body 6. The auxiliary side leaflet formation surface 10 faces the main body side leaflet formation surface 9 to form a leaflet formation space 12.

補助側弁尖形成面10は、その面上の位置ごとに、本体側弁尖形成面9からの距離を例えば0.2mm~2.0mmの範囲に設定され、例えば血圧への耐力及び血行動態を考慮しつつ、弁尖4を所望の弁尖厚分布に形成するようになっている。 The distance of the auxiliary side leaflet formation surface 10 from the main body side leaflet formation surface 9 is set in a range of, for example, 0.2 mm to 2.0 mm for each position on the surface, and for example, the distance from the main side valve leaflet formation surface 9 is set in the range of 0.2 mm to 2.0 mm, and the distance is set in the range of, for example, 0.2 mm to 2.0 mm. The valve leaflet 4 is formed to have a desired leaflet thickness distribution while taking this into consideration.

スリット18の幅は、隣接する2つの弁尖形成空間12の各側端部の厚さと仕切り壁14の厚さの合計に等しく、このスリット18の幅に対応して、弁付きグラフト5の交連部16の幅が十分な大きさに設定され、所定の強度の交連部16が形成される。 The width of the slit 18 is equal to the sum of the thickness of each side end of the two adjacent leaflet formation spaces 12 and the thickness of the partition wall 14, and the width of the slit 18 is equal to the sum of the thickness of the partition wall 14 and the commissure of the valve graft 5. The width of the portion 16 is set to a sufficient size, and the commissure portion 16 having a predetermined strength is formed.

補助基材7の端板17には、仕切り壁14の壁先部19の中央部分を露出させるY字形の弁先孔21が形成され、この弁先孔21を例えば0.5mm以上の幅に設定して、弁尖形成空間12のうちの複数の弁尖4の先端部に対応する部位と基材外部とを共通の弁先孔21によって連通させている。 A Y-shaped valve tip hole 21 is formed in the end plate 17 of the auxiliary base material 7 to expose the center portion of the wall tip 19 of the partition wall 14, and the valve tip hole 21 is made to have a width of, for example, 0.5 mm or more. The common valve tip hole 21 communicates between a portion of the valve leaflet formation space 12 corresponding to the tips of the plurality of valve leaflets 4 and the outside of the base material.

補助基材7の周面には、弁尖形成空間12と導管形成空間13とを連通する促進孔22が形成され、導管形成空間13から弁尖形成空間12への結合組織2の侵入を促進するようになっている。さらに、端板17に開口して促進孔22に至る範囲に切断用スリット23が形成され、弁付きグラフト5を取り外す際に、切断用スリット23にメスなどを挿入し、促進孔22の内部に形成されて補助基材7の内外を連結する結合組織2を切断するようになっている。 A promoting hole 22 is formed on the circumferential surface of the auxiliary base material 7 to communicate the valve leaflet formation space 12 and the duct formation space 13, and promotes the intrusion of the connective tissue 2 from the duct formation space 13 into the valve leaflet formation space 12. It is supposed to be done. Furthermore, a cutting slit 23 is formed in the range that opens in the end plate 17 and reaches the promoting hole 22. When removing the valved graft 5, a scalpel or the like is inserted into the cutting slit 23, and the inside of the promoting hole 22 is inserted. The connective tissue 2 that has been formed and connects the inside and outside of the auxiliary base material 7 is cut.

カバー基材8は、例えばアクリル樹脂などの高分子材料からなる円筒状とされ、その端部に形成された凹部24に、補助基材7の端板17から径方向外向きに突出する突起25を嵌合させることにより、基材本体6及び補助基材7の外周側に例えば2mm程度の一定の間隔をあけて取り付けられ、基材本体6及び補助基材7の外周面との間に導管形成空間13を構成する。カバー基材8には、ほぼ全面に広がるように侵入孔26が形成され、基材外部から導管形成空間13に結合組織2を容易に侵入させるようになっている。 The cover base material 8 has a cylindrical shape made of a polymeric material such as acrylic resin, and has a projection 25 projecting radially outward from the end plate 17 of the auxiliary base material 7 in a recess 24 formed at its end. By fitting them together, it is attached to the outer peripheral sides of the base material main body 6 and the auxiliary base material 7 with a constant interval of about 2 mm, for example, and a conduit is formed between the outer peripheral surfaces of the base material main body 6 and the auxiliary base material 7. A forming space 13 is configured. An entry hole 26 is formed in the cover base material 8 so as to extend over almost the entire surface, so that the connective tissue 2 can easily enter the conduit forming space 13 from the outside of the base material.

ここで、弁付きグラフト形成基材1の材料としては、生体に埋入した際に大きく変形することが無い強度(硬度)を有しており、化学的安定性があり、滅菌などの負荷に耐性があり、生体を刺激する溶出物が無いまたは少ない樹脂が好ましく、例えば、上記の通り、アクリル樹脂等が挙げられるがこれに限定されるものではない。 Here, the material of the valved graft formation base material 1 has a strength (hardness) that will not be significantly deformed when implanted in a living body, is chemically stable, and can withstand loads such as sterilization. Resins that are resistant and have no or little eluate that irritates living bodies are preferred, and examples include, but are not limited to, acrylic resins as described above.

次に、上記のような弁付きグラフト形成基材1を用いて弁付きグラフト5を生産する方法について説明する。 Next, a method for producing the valved graft 5 using the valved graft forming base material 1 as described above will be described.

図6に示すように、この生産方法は、弁付きグラフト形成基材1を生体組織材料の存在する環境に設置する「設置工程」と、弁付きグラフト形成基材1の周囲に結合組織2を形成して、その結合組織2を弁尖形成空間12及び導管形成空間13に侵入させる「形成工程」と、前記環境から結合組織2で被覆された弁付きグラフト形成基材1を取り出す「取出工程」と、弁付きグラフト形成基材から結合組織2を導管3及び弁尖4を含む弁付きグラフト5として分離する「分離工程」と、からなる。 As shown in FIG. 6, this production method includes an "installation step" in which the valved graft-forming base material 1 is installed in an environment where biological tissue material exists, and connective tissue 2 is placed around the valved graft-forming base material 1. a "formation step" in which the connective tissue 2 is formed and infiltrated into the valve leaflet formation space 12 and a conduit formation space 13; and a "removal step" in which the valved graft formation base material 1 covered with the connective tissue 2 is taken out from the environment. ” and a “separation step” of separating the connective tissue 2 from the valved graft forming substrate as a valved graft 5 including a conduit 3 and a valve leaflet 4 .

<設置工程>
基材本体6の端部に補助基材7を取り付けた後、突起25に嵌め込むようにして、基材本体6及び補助基材7の外周側にカバー基材8を取り付け、弁付きグラフト形成基材1を組み立てる。さらに、組み立てた弁付きグラフト形成基材1を例えばヤギの皮下などの生体組織材料の存在する環境に設置する(図6(a))。
<Installation process>
After attaching the auxiliary base material 7 to the end of the base material body 6, the cover base material 8 is attached to the outer periphery of the base material body 6 and the auxiliary base material 7 so as to fit into the protrusion 25, and the valved graft forming base material is formed. Assemble 1. Furthermore, the assembled graft-forming base material 1 with valves is placed in an environment where biological tissue material exists, such as under the skin of a goat (FIG. 6(a)).

生体組織材料の存在する環境とは、動物の生体内(例えば、皮下や腹腔内への埋入)、又は、動物の生体外において生体組織材料が浮遊する溶液中等の人工環境内が挙げられる。弁付きグラフト形成基材1を人工環境内へ置く場合には、種々の培養条件を整えてクリーンな環境下で公知の方法に従って細胞培養を行えばよい。生体組織材料としては、ヤギ、イヌ、ウシ、ブタ、ウサギ、ヒツジ、ヒトなどの哺乳類動物由来のものや、鳥類、魚類、その他の動物由来のもの、又は人工材料を用いることもできる。 The environment in which the living tissue material exists includes the inside of an animal's living body (for example, implanted subcutaneously or intraperitoneally), or the artificial environment such as a solution in which the living tissue material is suspended outside the animal's living body. When the valved graft-forming substrate 1 is placed in an artificial environment, various culture conditions may be set and cell culture may be performed in a clean environment according to known methods. As biological tissue materials, those derived from mammals such as goats, dogs, cows, pigs, rabbits, sheep, and humans, those derived from birds, fish, and other animals, or artificial materials can also be used.

<形成工程>
設置工程の後、例えば3か月程度の所定時間が経過することにより、弁付きグラフト形成基材1の周囲に結合組織2が形成されると共に、結合組織2が導管形成空間13の端部開口及びカバー基材8の侵入孔26から導管形成空間13に侵入する。さらに、導管形成空間13に侵入した結合組織2が侵入口11、スリット18及び促進孔22から弁尖形成空間12に侵入すると共に、弁先孔21を通って基材外部の結合組織2が直に弁尖形成空間12に侵入する(図6(b))。
<Formation process>
After the installation process, after a predetermined period of time, for example, about three months, connective tissue 2 is formed around the valved graft formation base material 1, and the connective tissue 2 is formed at the end opening of the conduit formation space 13. and enters the conduit forming space 13 through the entry hole 26 of the cover base material 8. Furthermore, the connective tissue 2 that has entered the conduit formation space 13 enters the valve leaflet formation space 12 through the entry port 11, the slit 18, and the promotion hole 22, and the connective tissue 2 outside the base material directly passes through the valve tip hole 21. It invades the valve leaflet formation space 12 (FIG. 6(b)).

この形成工程においては、弁先孔21を設けることにより、導管形成空間13を介する侵入に加えて、基材外部の結合組織2を直に侵入させる分、比較的に短時間で弁尖形成空間12に結合組織2が形成される。特に、複数の弁尖形成空間12を共通の弁先孔21で基材外部と連通させて、弁先孔21を大きくしているので、弁尖形成空間12への結合組織2の侵入がより促進される。結合組織2は、繊維芽細胞とコラーゲンなどの細胞外マトリックスで構成される。 In this forming process, by providing the valve tip holes 21, in addition to entering through the conduit forming space 13, the connective tissue 2 outside the base material can directly enter the valve leaflet forming space in a relatively short time. Connective tissue 2 is formed in 12. In particular, since the plurality of valve leaflet formation spaces 12 are communicated with the outside of the base material through a common valve tip hole 21 and the valve leaflet hole 21 is enlarged, the connective tissue 2 can more easily enter into the valve leaflet formation space 12. promoted. Connective tissue 2 is composed of fibroblasts and extracellular matrix such as collagen.

<取出工程>
所定時間の形成工程を経て、弁尖形成空間12及び導管形成空間13に結合組織2が十分に形成された後、結合組織2で被覆された弁付きグラフト形成基材1を生体組織材料の存在する環境から取り出す取出工程を行う。
<Removal process>
After the connective tissue 2 is sufficiently formed in the valve leaflet formation space 12 and the conduit formation space 13 through the formation process for a predetermined time, the valved graft formation base material 1 covered with the connective tissue 2 is placed in the presence of biological tissue material. Perform the extraction process to remove the material from the environment.

<分離工程>
カバー基材8の侵入孔26の内部に形成された結合組織2との間をメスなどで切断しながら、カバー基材8の外周面を覆う結合組織2を除去し、また、弁付きグラフト形成基材1の両端部の結合組織2を除去する。さらに、導管形成空間13の結合組織2を基材本体6及び補助基材7に残すようにピンセットなどで変形させて剥離しながらからカバー基材8を取り外す(図6(c))。
<Separation process>
The connective tissue 2 covering the outer peripheral surface of the cover base material 8 is removed while cutting with a scalpel or the like between the connective tissue 2 formed inside the penetration hole 26 of the cover base material 8, and a graft with a valve is formed. The connective tissue 2 at both ends of the base material 1 is removed. Furthermore, the cover base material 8 is removed after deforming and peeling the connective tissue 2 in the conduit forming space 13 with tweezers or the like so as to leave it on the base material main body 6 and the auxiliary base material 7 (FIG. 6(c)).

ここで、カバー基材8を取り外すことにより、導管3を構成する結合組織2が現れ、その表面には、カバー基材8の侵入孔26の内部に形成された結合組織2が突起状に残るが、導管3の外周面に突起があったとしても、血流などに影響を与えることがないので、特にこれを除去する必要はない。 By removing the cover base material 8, the connective tissue 2 forming the conduit 3 is exposed, and the connective tissue 2 formed inside the penetration hole 26 of the cover base material 8 remains in a protruding shape on the surface thereof. However, even if there is a protrusion on the outer circumferential surface of the conduit 3, it is not necessary to remove it because it does not affect the blood flow or the like.

結合組織2で覆われた切断用スリット23にメスなどを挿入し、補助基材7の促進孔22の内部に形成された結合組織2を切断して、導管3及び弁尖4を構成する補助基材7の内外の結合組織2を分離する。さらに、外周面及び補助側弁尖形成面10から結合組織2を剥離しながら補助基材7を取り外した後、基材本体6の仕切り壁14の壁先部19を覆う結合組織2を除去すると共に、導管3及び弁尖4に突起として残った促進孔22の内部の結合組織2を切除する(図6(d))。 A scalpel or the like is inserted into the cutting slit 23 covered with the connective tissue 2 to cut the connective tissue 2 formed inside the promoting hole 22 of the auxiliary base material 7 to form the duct 3 and the valve leaflets 4. The connective tissue 2 inside and outside the base material 7 is separated. Furthermore, after removing the auxiliary base material 7 while peeling the connective tissue 2 from the outer peripheral surface and the auxiliary leaflet formation surface 10, the connective tissue 2 covering the wall tip 19 of the partition wall 14 of the base material body 6 is removed. At the same time, the connective tissue 2 inside the promoting hole 22 remaining as a protrusion on the conduit 3 and the valve leaflet 4 is excised (FIG. 6(d)).

基材本体6の外周面及び本体側弁尖形成面9から剥離するように、基材本体6から結合組織2を分離することにより、弁付きグラフト5が得られる(図6(e))。 The valved graft 5 is obtained by separating the connective tissue 2 from the base material body 6 so as to be peeled off from the outer peripheral surface of the base material body 6 and the valve leaflet formation surface 9 on the body side (FIG. 6(e)).

図7に示すように、弁付きグラフト形成基材1を用いて生産した弁付きグラフト5は、例えば、心臓から出る大動脈などの血管に移植して弁機能を付与するための心臓弁グラフトであり、内側を流れる流体の圧力によって、導管3から半径方向内向きに膨出する複数の弁尖4が内外に変位することにより、導管3の内側の流路を開閉するようになっている。 As shown in FIG. 7, the valved graft 5 produced using the valved graft formation base material 1 is, for example, a heart valve graft that is implanted into a blood vessel such as the aorta that exits the heart to impart a valve function. A plurality of valve leaflets 4 bulging radially inward from the conduit 3 are displaced inwardly and outwardly by the pressure of the fluid flowing inside the conduit 3, thereby opening and closing the flow path inside the conduit 3.

弁尖4は、弁付きグラフト形成基材1のスリット18及び侵入口11に形成される交連部16及び弁元を導管3に接続され、流路の流れ方向が先端側から基端側に向かうとき、弁尖4と導管3との間に侵入しようとする流体の圧力によって、弁尖4が半径方向内向きに撓んで流路を閉じる(図7(a))。一方、流路の流れ方向が基端側から先端側に向かうとき、弁尖4が流れによって半径方向外向きに撓んで流路を開く(図7(b))。 In the valve leaflet 4, the commissure part 16 formed in the slit 18 and the entry port 11 of the valved graft formation base material 1 and the valve base are connected to the conduit 3, and the flow direction of the flow path is from the distal side to the proximal side. At this time, the pressure of the fluid that attempts to enter between the valve leaflet 4 and the conduit 3 causes the valve leaflet 4 to bend radially inward and close the flow path (FIG. 7(a)). On the other hand, when the flow direction of the flow path is from the proximal end to the distal end, the valve leaflets 4 are bent radially outward by the flow to open the flow path (FIG. 7(b)).

弁付きグラフト形成基材1を用いて生産した弁付きグラフト5は、その弁尖4を閉鎖状態の形状に形成されるので、自由状態が閉鎖状態であり、閉鎖の遅れに起因する逆流が生じるおそれを抑えることができる。 Since the valved graft 5 produced using the valved graft formation base material 1 is formed with its valve leaflets 4 in a closed state, the free state is in the closed state, and regurgitation occurs due to the delay in closure. It is possible to suppress the fear.

なお、本発明は、上記の実施の形態に限定されるものではなく、本発明の範囲内において、適宜変更を加えることができる。例えば、上記の形態では、特に三尖弁を例にして説明したが、二尖弁や四尖弁など、どのような尖数であってもよい。また、カバー基材8の侵入孔26や補助基材7の促進孔22及び切断用スリット23は、適宜省略することができる。また、弁尖孔は、共通のものだけでなく、各弁尖形成空間に対して1つの弁尖孔であってもよく、さらに、弁尖孔を省略することもできる。 Note that the present invention is not limited to the above-described embodiments, and changes can be made as appropriate within the scope of the present invention. For example, in the above embodiment, the tricuspid valve was specifically explained as an example, but the valve may have any number of cusps, such as a bicuspid valve or a four-cuspid valve. Moreover, the penetration hole 26 of the cover base material 8, the promotion hole 22 of the auxiliary base material 7, and the cutting slit 23 can be omitted as appropriate. Further, the leaflet hole is not limited to a common hole, and may be one leaflet hole for each leaflet formation space. Furthermore, the leaflet hole may be omitted.

1 弁付きグラフト形成基材
2 結合組織
3 導管
4 弁尖
5 弁付きグラフト
6 基材本体
7 補助基材
8 カバー基材
9 本体側弁尖形成面
10 補助側弁尖形成面
11 侵入口
12 弁尖形成空間
13 導管形成空間
14 仕切り壁
15 切欠き
16 交連部
17 端板
18 スリット
19 壁先部
20 嵌合溝
21 弁尖孔
22 促進孔
23 切断用スリット
24 凹部
25 突起
26 侵入孔
D 弁径
θ 弁閉鎖角
L 弁中心長
H 交連部高さ
a 交連部間距離
1 Valved graft formation base material 2 Connective tissue 3 Conduit 4 Valve leaflet 5 Valved graft 6 Base material body 7 Auxiliary base material 8 Cover base material 9 Main body side leaflet formation surface 10 Auxiliary side leaflet formation surface 11 Entry port 12 Valve Leaflet formation space 13 Conduit formation space 14 Partition wall 15 Notch 16 Commissure 17 End plate 18 Slit 19 Wall tip 20 Fitting groove 21 Leaflet hole 22 Promotion hole 23 Cutting slit 24 Recess 25 Projection 26 Penetration hole D Valve diameter θ Valve closing angle L Valve center length H Commissure height a Distance between commissures

Claims (4)

生体組織材料の存在する環境に設置して基材表面に結合組織を形成し、導管から半径方向内向きに膨出する複数の弁尖を有する弁付きグラフトを形成するための弁付きグラフト形成基材であって、
柱状の基材本体と、該基材本体の端部に着脱自在に取り付けられる補助基材とを備え、
前記基材本体及び前記補助基材に、弁尖厚さに対応する間隔をあけて対向する本体側弁尖形成面及び補助側弁尖形成面がそれぞれ設定され、該本体側弁尖形成面と補助側弁尖形成面との間が、外縁の侵入口から結合組織を侵入させて弁付きグラフトの弁尖を形成する弁尖形成空間とされ、
前記基材本体及び補助基材の外周側に筒状のカバー基材が設けられ、基材本体及び補助基材の外周面とカバー基材の内周面とが導管厚さに対応する間隔をあけて対向し、基材本体及び補助基材の外周面とカバー基材の内周面との間が、結合組織を侵入させて弁付きグラフトの導管を形成する導管形成空間とされたことを特徴とする弁付きグラフト形成基材。
A valved graft-forming group for placing in an environment where biological tissue material is present to form connective tissue on the surface of the substrate to form a valved graft having a plurality of leaflets bulging radially inward from a conduit. It is a material,
comprising a columnar base material body and an auxiliary base material detachably attached to the end of the base material body,
A main body side leaflet formation surface and an auxiliary side leaflet formation surface are respectively set on the base material main body and the auxiliary base material, and are opposed to each other with an interval corresponding to the leaflet thickness, and the main body side leaflet formation surface and The space between the auxiliary leaflet formation surface and the leaflet formation surface is defined as a leaflet formation space in which connective tissue is infiltrated from the entry port on the outer edge to form the leaflet of the valved graft;
A cylindrical cover base material is provided on the outer peripheral side of the base material main body and the auxiliary base material, and the outer peripheral surface of the base material main body and the auxiliary base material and the inner peripheral surface of the cover base material are spaced apart from each other corresponding to the thickness of the conduit. The space between the outer circumferential surfaces of the base material main body and auxiliary base material and the inner circumferential surface of the cover base material, which face each other with an open space, is used as a conduit forming space in which connective tissue is infiltrated to form a conduit of the valved graft. Features a valved graft-forming substrate.
前記補助基材に、弁尖形成空間のうちの弁尖の先端部に対応する部位と基材外部とを連通する弁先孔が形成されたことを特徴とする請求項1に記載の弁付きグラフト形成基材。 The valve-equipped valve according to claim 1, characterized in that the auxiliary base material is formed with a valve tip hole that communicates a portion corresponding to the tip of the valve leaflet in the valve leaflet formation space with the outside of the base material. Grafting substrate. 前記弁尖形成空間が弁尖の閉鎖状態の形状に設定され、複数の弁尖の先端部に対応する部位と基材外部とを連通する共通の弁先孔が形成されたことを特徴とする請求項2に記載の弁付きグラフト形成基材。 The valve leaflet formation space is set in the shape of the valve leaflet in a closed state, and a common valve tip hole is formed that communicates a portion corresponding to the tip portions of the plurality of valve leaflets with the outside of the base material. The valved grafting substrate of claim 2. 前記補助基材に、弁尖形成空間を導管形成空間と連通して弁尖形成空間への結合組織の侵入を促進する促進孔が形成されると共に、前記補助基材の端面から促進孔に至る範囲に、促進孔の内部に形成された結合組織を切断するための切断用スリットが形成されたことを特徴とする請求項1、2又は3に記載の弁付きグラフト形成基材。 A promotion hole is formed in the auxiliary base material to communicate the valve leaflet formation space with the conduit formation space to promote the invasion of connective tissue into the valve leaflet formation space, and the promotion hole extends from the end surface of the auxiliary base material. 4. The valved graft-forming base material according to claim 1, wherein a cutting slit for cutting the connective tissue formed inside the promoting hole is formed in the region.
JP2022040595A 2022-03-15 2022-03-15 Valved graft forming substrate Pending JP2023135411A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022040595A JP2023135411A (en) 2022-03-15 2022-03-15 Valved graft forming substrate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2022040595A JP2023135411A (en) 2022-03-15 2022-03-15 Valved graft forming substrate

Publications (1)

Publication Number Publication Date
JP2023135411A true JP2023135411A (en) 2023-09-28

Family

ID=88144584

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022040595A Pending JP2023135411A (en) 2022-03-15 2022-03-15 Valved graft forming substrate

Country Status (1)

Country Link
JP (1) JP2023135411A (en)

Similar Documents

Publication Publication Date Title
EP3231392B1 (en) Substrate for forming artificial valve and artificial valve
JP6010018B2 (en) Stent with valve, base material for forming stent with valve, and production method of stent with valve
RU2314777C2 (en) Intraparietal reinforcing assembly for biological prosthetic appliance and biological prosthetic appliance
US9017396B2 (en) Prosthetic valves for medical application
WO2016076416A1 (en) Connective tissue formation substrate and substrate removal tool
JP2015039515A (en) Prosthetic valve, base material for forming prosthetic valve, and production procedure of prosthetic valve
JP6262470B2 (en) Substrate for forming connective tissue and method for producing connective tissue
JP5676115B2 (en) Artificial blood vessel with valve, columnar core substrate for artificial blood vessel with valve, and method for producing artificial blood vessel with valve
JP2023135411A (en) Valved graft forming substrate
JP2017169778A (en) Connective tisse body forming substrate
JP6159041B1 (en) Artificial valve
EP3583917A1 (en) Artificial heart valve
JP5658008B2 (en) Artificial blood vessel forming substrate with valve, production method of artificial blood vessel with valve using the same, and artificial blood vessel with valve
JP2015039577A (en) Prosthetic valve, base material for forming prosthetic valve, and production procedure of prosthetic valve
JP2016136984A (en) Tubular tissue body forming substrate
JP2021122747A (en) Structure for connective tissue body formation and method for forming connective tissue body
JP2017113051A (en) Membrane-like connective tissue body formation base material
US20210169643A1 (en) Prosthetic Heart Valves
EP2873428A1 (en) Substrate for formation of membrane-like connective tissue and production method for membrane-like connective tissue using same
WO2014021073A1 (en) Artificial cornea, and method for producing artificial cornea
JP2021122277A (en) Structural assembly for connective tissue formation and method for forming connective tissue
JP5706282B2 (en) Lumen-shaped tissue forming substrate with valve, lumen-shaped tissue forming substrate, membranous tissue-forming substrate, valved lumen-shaped tissue production method, lumen-shaped tissue production method, and membranous tissue Production method
RU19360U1 (en) PROSTHETIC HEART VALVE